Manufacturing News of Note—Thermo Fisher closes on GSK plant; Vetter invests $100M; Lupin names ex-Apotex exec head of quality 

stocks
(Pixabay)

> Waltham, Massachusetts-based Thermo Fisher Scientific has completed its €90 million buyout of a GlaxoSmithKline API site in Cork, Ireland. Release 

> German CDMO Vetter says it will invest $100 million to upgrade its production lines at sites in Germany and the U.S. to increase filling capacity. Story

> Lupin, which has been struggling with manufacturing quality, has named as its new global head of quality Johnny Mikell. He comes from Apotex, another drugmaker with a history of FDA manufacturing issues. Release 

> Lupin has received a Form 483 with three observations for its Tarapur plant. Story 

> South Plainfield, New Jersey-based biotech PTC Therapeutics has struck a deal with Aldevron to manufacture its gene therapy portfolio. Release 

> Boehringer Ingelheim has completed a $76 million expansion at its plant at Athens, Georgia, which doubles its pet vaccine capacity. Release

> Merck KGaA’s MilliporeSigma has acquired for an undisclosed amount Wilbraham, Massachusetts-based FloDesign Sonics, which has developed an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Release